细菌性阴道病的抗菌治疗：现有和新兴疗法。
Antibacterial treatment of bacterial vaginosis: current and emerging therapies.
机构信息
Pôle Enfance et Famille, Conseil Général du Val-de-Marne, Créteil, France.
出版信息
Int J Womens Health. 2011;3:295-305. doi: 10.2147/IJWH.S23814. Epub 2011 Aug 23.
Abstract
Bacterial vaginosis is a common cause of malodorous vaginal discharge. It is also associated with sexually transmitted infections and adverse pregnancy outcomes. The magnitude of the gynecological and obstetrical consequences has stimulated therapeutic research and led to the testing of several therapies. The objective of this work is to present the currently available therapeutic strategies for the treatment of bacterial vaginosis and associated recommendations, and discuss the emerging therapies.
摘要
细菌性阴道病是一种常见的有异味阴道分泌物的原因。它也与性传播感染和不良妊娠结局有关。妇科和产科后果的严重程度刺激了治疗研究，并导致了几种治疗方法的测试。本工作的目的是介绍目前可用于治疗细菌性阴道病和相关建议的治疗策略，并讨论新兴的治疗方法。
相似文献
1
Antibacterial treatment of bacterial vaginosis: current and emerging therapies.
Int J Womens Health. 2011;3:295-305. doi: 10.2147/IJWH.S23814. Epub 2011 Aug 23.
2
Bacterial vaginosis: current review with indications for asymptomatic therapy.
Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1210-7. doi: 10.1016/s0002-9378(12)90729-2.
3
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
J Obstet Gynaecol Can. 2015 Mar;37(3):266-274. doi: 10.1016/S1701-2163(15)30316-9.
4
Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis.
Obstet Gynecol. 2005 Jul;106(1):105-14. doi: 10.1097/01.AOG.0000163247.78533.7b.
5
Bacterial vaginosis: a threat to reproductive health? Historical perspectives, current knowledge, controversies and research demands.
Eur J Contracept Reprod Health Care. 2000 Sep;5(3):208-19. doi: 10.1080/13625180008500398.
6
[Bacterial vaginosis].
Enferm Infecc Microbiol Clin. 2016 Jul;34 Suppl 3:14-8. doi: 10.1016/S0213-005X(16)30214-2.
7
Bacterial vaginosis: many questions--any answers?
Curr Opin Pediatr. 2005 Aug;17(4):473-9. doi: 10.1097/01.mop.0000170516.35272.45.
8
Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions.
Front Microbiol. 2016 Jan 20;6:1528. doi: 10.3389/fmicb.2015.01528. eCollection 2015.
9
Targeted point-of-care testing compared with syndromic management of urogenital infections in women (WISH): a cross-sectional screening and diagnostic accuracy study.
Lancet Infect Dis. 2019 Jun;19(6):658-669. doi: 10.1016/S1473-3099(18)30724-2. Epub 2019 Apr 25.
10
Bacterial vaginosis.
Prim Care Update Ob Gyns. 2000 Sep 1;7(5):181-185. doi: 10.1016/s1068-607x(00)00043-3.
引用本文的文献
1
Exploring the vaginal ecosystem: insights into host-microbe interactions and microbial community dynamics.
Infect Immun. 2025 Sep 9;93(9):e0049924. doi: 10.1128/iai.00499-24. Epub 2025 Aug 11.
2
Leveraging the microbiome to combat antibiotic resistant gynecological infections.
NPJ Antimicrob Resist. 2025 Apr 23;3(1):32. doi: 10.1038/s44259-025-00106-2.
3
Efficacy and safety of different drugs for the treatment of bacterial vaginosis: a systematic review and network meta-analysis.
Front Cell Infect Microbiol. 2024 Oct 11;14:1402346. doi: 10.3389/fcimb.2024.1402346. eCollection 2024.
4
Computational approach for drug discovery against Gardnerella vaginalis in quest for safer and effective treatments for bacterial vaginosis.
Sci Rep. 2024 Jul 29;14(1):17437. doi: 10.1038/s41598-024-68443-2.
5
Bacterial Vaginosis (BV) and Vaginal Microbiome Disorders in Women Suffering from Polycystic Ovary Syndrome (PCOS).
Diagnostics (Basel). 2024 Feb 12;14(4):404. doi: 10.3390/diagnostics14040404.
6
Mesh and layered electrospun fiber architectures as vehicles for Lactobacillus acidophilus and Lactobacillus crispatus intended for vaginal delivery.
Biomater Adv. 2023 Nov;154:213614. doi: 10.1016/j.bioadv.2023.213614. Epub 2023 Aug 29.
7
Rapid-dissolving electrospun nanofibers for intra-vaginal antibiotic or probiotic delivery.
Eur J Pharm Biopharm. 2023 Sep;190:81-93. doi: 10.1016/j.ejpb.2023.07.009. Epub 2023 Jul 19.
8
Sorangicin A Is Active against in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment.
Antibiotics (Basel). 2023 Apr 22;12(5):795. doi: 10.3390/antibiotics12050795.
9
Formulation and characterization of pressure-assisted microsyringe 3D-printed scaffolds for controlled intravaginal antibiotic release.
Int J Pharm. 2023 Jun 25;641:123054. doi: 10.1016/j.ijpharm.2023.123054. Epub 2023 May 18.
10
Lactobacillus crispatus-loaded electrospun fibers yield viable and metabolically active bacteria that kill Gardnerella in vitro.
Eur J Pharm Biopharm. 2023 Jun;187:68-75. doi: 10.1016/j.ejpb.2023.04.011. Epub 2023 Apr 20.
本文引用的文献
1
Preparation and anti-bacterial properties of a temperature-sensitive gel containing silver nanoparticles.
Pharmazie. 2011 Apr;66(4):272-7.
2
Controlled study on thymol + eugenol vaginal douche versus econazole in vaginal candidiasis and metronidazole in bacterial vaginosis.
Arzneimittelforschung. 2011;61(2):126-31. doi: 10.1055/s-0031-1296178.
3
Pilot randomized trial for treatment of bacterial vaginosis using in situ forming metronidazole vaginal gel.
J Obstet Gynaecol Res. 2011 Jul;37(7):874-81. doi: 10.1111/j.1447-0756.2010.01457.x. Epub 2011 Mar 16.
4
Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102.
Contraception. 2011 Apr;83(4):295-309. doi: 10.1016/j.contraception.2010.11.006. Epub 2011 Feb 12.
5
The aetiology of bacterial vaginosis.
J Appl Microbiol. 2011 May;110(5):1105-28. doi: 10.1111/j.1365-2672.2011.04977.x. Epub 2011 Mar 14.
6
In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis?
Antimicrob Agents Chemother. 2011 May;55(5):2490-2. doi: 10.1128/AAC.01623-10. Epub 2011 Feb 14.
7
The vaginal microbiome: new information about genital tract flora using molecular based techniques.
BJOG. 2011 Apr;118(5):533-49. doi: 10.1111/j.1471-0528.2010.02840.x. Epub 2011 Jan 20.
8
Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: in vitro study.
Arzneimittelforschung. 2010;60(11):675-81. doi: 10.1055/s-0031-1296346.
9
Tinidazole vs metronidazole for the treatment of bacterial vaginosis.
Am J Obstet Gynecol. 2011 Mar;204(3):211.e1-6. doi: 10.1016/j.ajog.2010.10.898. Epub 2010 Dec 17.
10
Probiotic strategies for the treatment and prevention of bacterial vaginosis.
Expert Opin Pharmacother. 2010 Dec;11(18):2985-95. doi: 10.1517/14656566.2010.512004.
Zotero 插件